CroíValve Raises an €8M Series A Round
The funding will support a European Feasibility Study of the CroíValve Transcatheter Tricuspid DUO Coaptation Valve System.
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
The funding will support a European Feasibility Study of the CroíValve Transcatheter Tricuspid DUO Coaptation Valve System.
The financial resources offered by this second round of financing of €5 million will enable the company to accelerate the commercial deployment of deepLive™ in Europe and to push the development of our product even further.
The funding from Magnetar will help enFuse continue to redefine intravenous drug delivery by meaningfully scaling development and commercialization efforts.